NatWest Group’s HI-TECH PHARMACAL INC HITK Stock Holding History

NatWest Group’s Portfolio HITK Stock Details HITK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q3	–	Sell	-24,742	Closed	-$821K	–	1075
2013 Q2	$821K	Buy	+24,742	New	+$823K	0.01%	507

Other funds holding HITK

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

NatWest Group's HITK Position: Q3 2013 in Review

NatWest Group sold out of HI-TECH PHARMACAL INC (HITK) in Q3 2013, closing a stake of 24,742 shares — an estimated $821K sold.

NatWest Group first reported a position in HITK in Q2 2013 and held it in 1 quarter. The position peaked at $821K in Q2 2013. 105 funds tracked by Wall St. Rank hold HITK as of Q3 2013.

NatWest Group reported no remaining HI-TECH PHARMACAL INC position as of Q3 2013 after selling out during the quarter.
NatWest Group sold 24,742 HI-TECH PHARMACAL INC shares in Q3 2013, an estimated $821K.
NatWest Group first reported a position in HI-TECH PHARMACAL INC in Q2 2013 and held it in 1 quarter.
NatWest Group's HI-TECH PHARMACAL INC position peaked at $821K in Q2 2013.
105 funds tracked by Wall St. Rank held HI-TECH PHARMACAL INC as of Q3 2013.

Based on NatWest Group's 13F filing for Q3 2013, filed 14 Nov 2013.